Postmenopausal women were separated into two groups: one participating in a 12-week fitness walking programe as the fitness walking group, and the other maintaining their regular lifestyle as the control group. The study evaluated alterations in health markers and examined the correlation between metabolic syndrome risk factors and sex hormone levels before and after the intervention.
According to the inclusion and exclusion criteria, our study invlved postmenopausal women aged from 50 to 69 years old. After the selection process, baseline assessments were conducted, including evaluations of metabolic syndrome risk factors, body morphology measurements, sex hormone levels, and cardiopulmonary exercise testing. Participants were then randomly assigned to either the fitness walking group or the control group using a random number table. Participants in the fitness walking group completed a 12-week fitness walking program, while those in the control group maintained their usual lifestyle without any intervention. During the post-intervention assessment, all baseline measurements were repeated to evaluate changes in the previously measured indicators.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
30
Fitness walking for 12 weeks.
Maintained their normal lifestyle, without exercise intervention.
School of Sports Medicine and Rehabilitation, Beijing Sport University
Beijing, China
School of Sports Medicine and Rehabilitation
Beijing, China
Systolic blood pressure (SBP)
The change of SBP before and after intervention
Time frame: At the beginning-at 12 weeks.
Diastolic blood pressure (DBP)
The change of DBP before and after intervention
Time frame: At the beginning-at 12 weeks.
Waist circumference (WC)
The change of WC before and after intervention
Time frame: At the beginning-at 12 weeks.
Fasting blood glucose (FBG)
The change of FBG before and after intervention
Time frame: At the beginning-at 12 weeks.
Triglycerides (TG)
The change of TG before and after intervention
Time frame: At the beginning-at 12 weeks.
High-density lipoprotein cholesterol (HDL-C)
The change of HDL-C before and after intervention
Time frame: At the beginning-at 12 weeks.
Oestradiol (E2)
The change of E2 before and after intervention
Time frame: At the beginning-at 12 weeks.
Testosterone (T)
The change of T before and after intervention
Time frame: At the beginning-at 12 weeks.
Sex hormone-binding globulin (SHBG)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The change of SHBG before and after intervention
Time frame: At the beginning-at 12 weeks.
Dehydroepiandrosterone sulphate (DHEA-S)
The change of DHEA-S before and after intervention
Time frame: At the beginning-at 12 weeks.
Maximal oxygen uptake (VO2max)
The change of VO2max before and after intervention
Time frame: At the beginning-at 12 weeks.
Body weight (BW)
The change of BW before and after intervention
Time frame: At the beginning-at 12 weeks.
Height
The change of height before and after intervention
Time frame: At the beginning-at 12 weeks.
Body mass index (BMI)
The change of BMI before and after intervention
Time frame: At the beginning-at 12 weeks.